Literature DB >> 11830761

Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug.

I Lapin1.   

Abstract

Phenibut (beta-phenyl-gamma-aminobutyric acid HCl) is a neuropsychotropic drug that was discovered and introduced into clinical practice in Russia in the 1960s. It has anxiolytic and nootropic (cognition enhancing) effects. It acts as a GABA-mimetic, primarily at GABA(B) and, to some extent, at GABA(A) receptors. It also stimulates dopamine receptors and antagonizes beta-phenethylamine (PEA), a putative endogenous anxiogenic. The psychopharmacological activity of phenibut is similar to that of baclofen, a p-Cl-derivative of phenibut. This article reviews the structure-activity relationship of phenibut and its derivatives. Emphasis is placed on the importance of the position of the phenyl ring, the role of the carboxyl group, and the activity of optical isomers. Comparison of phenibut with piracetam and diazepam reveals similarities and differences in their pharmacological and clinical effects. Phenibut is widely used in Russia to relieve tension, anxiety, and fear, to improve sleep in psychosomatic or neurotic patients; as well as a pre- or post-operative medication. It is also used in the therapy of disorders characterized by asthenia and depression, as well as in post-traumatic stress, stuttering and vestibular disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11830761      PMCID: PMC6494145          DOI: 10.1111/j.1527-3458.2001.tb00211.x

Source DB:  PubMed          Journal:  CNS Drug Rev        ISSN: 1080-563X


  25 in total

Review 1.  Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.

Authors:  Matthew I Hardman; Juraj Sprung; Toby N Weingarten
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

2.  Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report.

Authors:  Yash B Joshi; Samantha F Friend; Berenice Jimenez; Louisa R Steiger
Journal:  J Clin Psychopharmacol       Date:  2017-08       Impact factor: 3.153

3.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 4.  Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.

Authors:  Edward A Jouney
Journal:  Curr Psychiatry Rep       Date:  2019-03-09       Impact factor: 5.285

5.  Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface.

Authors:  Lei Liu; Zhiran Fan; Xavier Rovira; Li Xue; Salomé Roux; Isabelle Brabet; Mingxia Xin; Jean-Philippe Pin; Philippe Rondard; Jianfeng Liu
Journal:  Elife       Date:  2021-12-06       Impact factor: 8.140

6.  Phenibut dependence.

Authors:  Andriy V Samokhvalov; C Lindsay Paton-Gay; Kam Balchand; Jürgen Rehm
Journal:  BMJ Case Rep       Date:  2013-02-06

7.  One-pot synthesis of GABA amides via the nucleophilic addition of amines to 3,3-disubstituted cyclopropenes.

Authors:  Vladimir A Maslivetc; Marina Rubina; Michael Rubin
Journal:  Org Biomol Chem       Date:  2015-08-05       Impact factor: 3.876

Review 8.  GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.

Authors:  A Nieto; T Bailey; K Kaczanowska; P McDonald
Journal:  Curr Top Behav Neurosci       Date:  2022

9.  Highly Diastereoselective Construction of Carbon- Heteroatom Quaternary Stereogenic Centers in the Synthesis of Analogs of Bioactive Compounds: From Monofluorinated Epoxyalkylphosphonates to α-Fluoro-, β-, or γ-Amino Alcohol Derivatives of Alkylphosphonates.

Authors:  Magdalena Rapp; Klaudia Margas-Musielak; Patrycja Kaczmarek; Agnieszka Witkowska; Tomasz Cytlak; Tomasz Siodła; Henryk Koroniak
Journal:  Front Chem       Date:  2021-06-02       Impact factor: 5.221

Review 10.  Molecular mechanisms of metabotropic GABAB receptor function.

Authors:  Hamidreza Shaye; Benjamin Stauch; Cornelius Gati; Vadim Cherezov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.